Recombinant Therapeutic Antibodies and Proteins Market Growth by (2019-2027)
Key players in the market are focused on combining various methodologies to develop novel recombinant therapeutic drugs. This in turn has enabled manufacturers to modify certain basic features of proteins in order to increase product quality and safety. Use of several recombinant methodologies has enhanced the half-life, functionality, and targeting ability of new therapeutic protein drugs. It has also helped to enhance the quality of products and volume. For instance, protein conjugation and derivatization methods, including albumin-fusion15, PEGylation and Fc-fusion...
View full press release